Antacid suspension product recalled due to microbial contamination
Plastikon Healthcare LLC is recalling 23,300 antacid suspension cups due to microbial contamination. The product was distributed in Indiana for institutional use.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recall classification requires minimum severity score of 4. No reported deaths or serious injuries in the source material.
Plain-English summary
Plastikon Healthcare LLC is recalling 23,300 Unit Dose cups of an antacid suspension. The product contains magnesium hydroxide 1200mg, aluminum hydroxide 1200mg, and simethicone 120mg per 30 mL cup. The recalled product is lot 21067A with an expiration date of June 2023, and was distributed in Indiana for further distribution throughout the United States.
The U.S. Food and Drug Administration (FDA) issued this Class I recall due to microbial contamination of the non-sterile product.
This product is intended for institutional use only. Consumers and healthcare facilities in possession of this product should not use it. Contact Plastikon Healthcare LLC or the distributor, Major Pharmaceuticals, for instructions on return or disposal of the recalled product.
The recalled product
- Product
- Magnesium Hydroxide 1200mg, Aluminum Hydroxide 1200mg, Simethicone 120mg, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Distribute by Major Pharmaceuticals, Livonia, MI 48152, NDC: 0904-6838-73.
- Manufacturer
- Plastikon Healthcare LLC
- Category
- Drug — Antacid suspension
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 21067A
- EXP Jun 2023
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27